KiranDevisettyMD

Radiation Oncology, Memorial Health University Medical Center & South Georgia Center for Cancer Care; Clinical Associate Professor, Mercer University School of Medicine

Join to view full profile

Dr. Devisetty is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Devisetty's full profile

Already have an account?

Office
3900 Woodland Ave
Philadelphia, PA 19104
Phone+1 215-823-5800

Fax+1 912-764-3829

Summary

I am a board certified radiation oncologist practicing at the Memorial Health University Medical Center and South Georgia Center for Cancer Care and a Clinical Associate Professor at Mercer University School of Medicine. I work with a multi-disciplinary team to treat adult & pediatric patients with cancer. My practice specializes in stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), 3D conformal radiation therapy (3DCRT), high dose rate brachytherapy (skin, prostate, gynecologic cancers), low dose rate brachytherapy (prostate cancer), and radioactive nuclides (prostate, liver, thyroid cancers). I also have extensive prior experience with proton therapy.

Kiran Devisetty Memorial Healthcare's Live Healthy Interview 2 (2021.09)

Dr. Devisetty is interviewed by WTOC-11 to discuss treatments for prostate cancer as part of Memorial Healthcare's Live Healthy campaign.

Kiran Devisetty's Memorial Healthcare's Live Healthy Interview 1 (2021.09)

Dr. Devisetty is interviewed by WTOC-11 to discuss risk factors for prostate cancer as part of Memorial Healthcare's Live Healthy campaign.

Kiran Devisetty's Karmanos Cancer Institute Interview (2019.02.23)

Dr. Devisetty is interviewed about his practice and philosophy in radiation oncology and his passion for taking care of cancer patients.

Kiran Devisetty's The Breast of Everything Podcast (2020.12.10)

Dr. Devisetty is interviewed by Dr. Ashley Richardson for The Breast of Everything Podcast to discuss why radiation therapy is used or breast cancer.

Kiran Devisetty's WJR Radio Interview, part 2 (2020.01.30)

Dr. Devisetty is interviewed by Guy Gordon of WJR 760 AM to discuss the Karmanos Cancer Network nationally recognized clinical trials program.

Kiran Devisetty's WJR Radio Interview, part 1 (2020.01.30)

Dr. Devisetty is interviewed by Guy Gordon of WJR 760 AM to discuss the Karmanos Cancer Network's commitment to evidenced based and patient centered cancer care

Kiran Devisetty's McLaren Proton Therapy Center Video

Kiran Devisetty, MD reviews the advantages of proton therapy and the McLaren Proton Therapy Center.

Kiran Devisetty's NBC25 News TV Interview on Prostate Cancer Screening (2013.02.

NBC25 News TV interview discussing indications, benefits, and shared decision making for prostate cancer screening.

Kiran Devisetty's ABC12 News Interview on GBM (2018.09.02)

ABC12 News TV interview discussing prognosis and treatment of glioblastoma multiforme (GBM).

McLaren Medical Minutes

Dr. Devisetty speaks about the radiation oncology department at the Karmanos Cancer Institute at McLaren Flint.

Clinical Expertise

Esophageal cancer, Squamous cell carcinoma of the esophagus, Gastric cancer, Colorectal cancer, Pancreatic cancer, Adenocarcinoma of the lung, Squamous cell carcinoma of the lung, Breast cancer, Hepatobiliary cancer, Lung cancer, Prostate cancer, Adenocarcinoma of the prostate, Skin cancer, Head and neck cancer, Squamous cell carcinoma of the salivary glands, Squamous cell carcinoma of the paranasal sinus, Squamous cell carcinoma of the oral cavity, Squamous cell carcinoma of the lip, Squamous cell carcinoma of the trachea, Hereditary prostate cancer, Squamous cell carcinoma of the vulva, Squamous cell carcinoma of the vagina, Squamous cell carcinoma of the cervix, Endometrial carcinoma, Medullary thyroid carcinoma, Papillary thyroid carcinoma, Follicular thyroid carcinoma, Prostate cancer screening, Primary brain tumors, Thyroid cancer, Lymphoma, Branchiogenic carcinoma, Squamous cell carcinoma of the ear, Squamous cell carcinoma of the nose, Small cell lung cancer, Non-small cell lung cancer, Thyroid and parathyroid cancer, Bladder cancer, Squamous cell carcinoma of unknown head and neck primary, Uterine cancer, Cervical cancer, Sarcomas, Squamous cell carcinoma of the skin, Tubular carcinoma of the breast, Epidermoid cancer of the anus, Adenocarcinoma of the nasal cavity or paranasal sinuses, Squamous cell carcinoma of the oropharynx, Spindle cell carcinoma of the larynx, Verrucous cancer of the larynx, Organ-sparing laryngeal cancer surgery, Squamous cell carcinoma of the floor of the mouth, Squamous cell carcinoma of the buccal mucosa, Squamous cell carcinoma of the tongue, Squamous cell carcinoma of the retromolar trigone, Squamous cell carcinoma of the alveolar ridge, Hepatic metastases, Squamous cell carcinoma of the gallbladder, Squamous cell carcinoma of the temporal bone, Thyroid neoplasms, Squamous cell carcinoma of the nasal cavity, Radiation oncology, Clincial trials, Oncologic pathology, Urethral cancer, Erectie dysfunction

Education & Training

University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 2005 - 2009
Loyola Medicine MacNeal HospitalInternship, Transitional Year, 2004 - 2005
University of Michigan Medical SchoolClass of 2004
George Washington UniversityB.S., Summa Cum Laude & Special Honors, 1995 - 1998

Certifications & Licensure

GA State Medical License 2020 - 2024
PA State Medical License 2024 - 2024
MI State Medical License 2012 - 2022
WI State Medical License 2009 - 2021
IL State Medical License 2007 - 2009
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Health Policy Fellowship ASTRO, 2021
McLaren Flint Physician of the Year (Q4) McLaren Flint, 2019
Outstanding Reviewer International Journal of Radiation Oncology, Biology, Physics, 2017
Outstanding Research Achievement Award Karmanos Cancer Network, 2016
Research Methods in Clinical Cancer Research Fellow American Society of Clinical Oncology/American Association for Cancer, 2011
Radiation Oncology Chief Resident The University of Chicago Hospitals, 2007
Alpha Omega Alpha Honor Society University of Michigan Medical School, 2003
NIH Research Scholars Fellowship Howard Hughes Medical Institute, 2002
Government Relations Fellowship American Medical Association, 2000
Theta Alpha Kappa Honor Society George Washington University, 1998
Phi Beta Kappa Honor Society George Washington University, 1998
Summa Cum Laude with Special Honors George Washington University, 1998
Dean's List George Washington University, 1995-1998
Distinguished Scholar George Washington University, 1995-1998
Presidential Scholarship George Washington University, 1995-1998
Honors Program George Washington University, 1995-1998
Join now to see all

Clinical Trials

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2011 Jul 01
Active, not recruiting
Phase 3
Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer Start of enrollment: 2013 Apr 01
Active, not recruiting
Phase 3
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery Start of enrollment: 2013 Aug 01
Active, not recruiting
Not Applicable
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy Start of enrollment: 2014 Feb 07
Active, not recruiting
Phase 3
Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy Start of enrollment: 2015 Mar 28
Active, not recruiting
Phase 2
Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial Start of enrollment: 2016 Feb 01
Active, not recruiting
Not Applicable
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer Start of enrollment: 2015 Dec 07
Active, not recruiting
Phase 2, Phase 3
Breast Cancer WEight Loss Study (BWEL Study) Start of enrollment: 2016 Aug 01
Active, not recruiting
Phase 3
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). Start of enrollment: 2016 Jul 01
Active, not recruiting
Phase 3
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer Start of enrollment: 2017 Jan 11
Completed
Phase 2
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy Start of enrollment: 2016 Dec 08
Terminated
Phase 3
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery Start of enrollment: 2017 Jan 16
Active, not recruiting
Phase 2, Phase 3
Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer Start of enrollment: 2017 Apr 07
Active, not recruiting
Phase 2
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer Start of enrollment: 2018 Jul 05
Active, not recruiting
Phase 3
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin Start of enrollment: 2018 Apr 03
Active, not recruiting
Phase 2, Phase 3
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer Start of enrollment: 2017 Nov 16
Active, not recruiting
Phase 3
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer Start of enrollment: 2018 Mar 12
Active, not recruiting
Phase 3
A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer Start of enrollment: 2018 Jul 05
Active, not recruiting
Not Applicable
Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), The ARCHON-1 Trial Start of enrollment: 2019 Oct 28
Recruiting
Phase 1
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery Start of enrollment: 2019 Apr 15
Active, not recruiting
Phase 2
Durvalumab vs Placebo With Stereotactic Body Radiation Therapy in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients / Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation Start of enrollment: 2019 Mar 06
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

436 citations
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
Paul D. Brown, Vinai Gondi, Stephanie L. Pugh, Wolfgang A. Tomé, Jeffrey S. Wefel
Journal of Clinical Oncology. 2020-02-14
7 citations
Neoadjuvant Versus Induction Chemotherapy: More Than Semantics
Kiran Devisetty, Stuart J. Wong
Journal of Clinical Oncology. 2013-08-10
14 citations
A Three-Dimensional Bioabsorbable Tissue Marker for Volume Replacement and Radiation Planning: A Multicenter Study of Surgical and Patient-Reported Outcomes for 818 Pa...
Cary S. Kaufman, Michael J. Cross, Julie L. Barone, Nayana Dekhne, Kiran Devisetty
Annals of Surgical Oncology. 2021-05-01

Books/Book Chapters

Principles and Practice of Neuro-Oncology: A Multidisciplinary Approach
Chapter: Tumors of the Base of Skull: Chordoma & Chondrosarcoma
Devisetty K, Malyapa RS, Mendenhall WMEditors: Mehta, Chang, Vogelbaum, Guha, et al.Demos Medical Publishing, Woodbridge2011

Lectures

Regional Lymphatic Radiation: Not All N1 Are Created Equal
Karmanos Cancer Institute 2018 Breast Cancer Symposium - 3/2018
Complications of Head & Neck Radiation
American Osteopathic Colleges of Ophthalmology and Otolaryngology 99th Annual Meeting - 5/2015
Improving the Precision and Safety of Delivery Radiotherapy: Proton Beam
Karmanos Cancer Institute 9th Annual Gastrointestinal Cancers Symposium - 11/2014

Professional Memberships

American Society for Radiation Oncology - ASTRO
Member
American Society of Clinical Oncology - ASCO
Member
American Medical Association - AMA
Member

External Links

LinkedInhttp://www.linkedin.com/in/kirandevisetty
Memorial Health University Medical Centerhttps://memorialhealth.com/physicians/profile/Dr-Kiran-Devisetty-MD
South Georgia Center for Cancer Carehttps://sgcancer.com/dr-kiran-devisetty/